Panel Discussion: Current Efforts to Spearhead Regulatory Modernisation & Acceptance of Novel CGT Technologies
- Share how regulators in Europe, the US, and Asia are adapting frameworks to keep pace with emerging cell and gene therapy technologies
- Highlight initiatives that foster earlier and more constructive engagement
- Understand how modernisation efforts can accelerate approvals, support broader adoption, and make CGTs more commercially viable